FB Pixel no script
MENU
KrASIA

Hong Kong

Insights

Hong Kong biotech enters its second act with a licensing supercycle

New capital, maturing pipelines, and a more global R&D mindset are pushing valuations higher, even as competition tightens.

14 mins read
  • Bringing you the latest updates on funding deals and activities in the Asia Pacific.

    News

    Deals in brief: Respiree raises Series A funding, HeyMax expands with Krip acquisition, latest China deals, and more

    4 mins read

Most Recent

See All